AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12117747
Drug: Dexrazoxane (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexrazoxane (500 mg/m2)
Trial: 10088770
Drug: Intraarticular corticosteroids
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular corticosteroids (3.75 mg of cortivazol in 1.5 ml)
Trial: 10088770
Drug: Intraarticular placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular placebo (1.5 ml of 0.9% normal saline)
Trial: 7491940
Drug: 56 mg
RxNorm normalized name: aspirin 856 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 56 mg arginine.kg‐1.day‐1 for 6 days
Trial: 7491940
Drug: 561 mg
RxNorm normalized name: OCTINOXATE 2.1 mg in 30 mL / OCTISALATE 0.9 mg in 30 mL / TITANIUM DIOXIDE 2.561 mg in 30 mL TOPICAL CREAM [CLE CCC Olive Medium Deep]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 561 mg arginine.kg‐1.day‐1 for 6 days
Trial: 23365148
Drug: Ayurvedic formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ayurvedic formulations (SGCG and SGC)
Trial: 23365148
Drug: Glucosamine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucosamine (2 g daily)
Trial: 8751544
Drug: Paclitaxel (135
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (135 or 175 mg/m2) over 3 hr followed by cisplatin (75 mg/m2)
Trial: 1910100
Drug: Immediate postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate postoperative nasojejunal feeding with full strength Osmolite solution for 56 hours (n = 16)
Trial: 29395424
Drug: Intramuscular injections
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injections of allogeneic MSCs
Trial: 25236322
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clindamycin phosphate plus benzoyl peroxide
Trial: 16297756
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion with a preset target concentration of 2.5 microg/mL until sedation level 3 was achieved.
Trial: 9704200
Drug: Phenylbutazone 10
RxNorm normalized name: phenylbutazone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylbutazone 10 mg/kg intramuscularly
Trial: 9704200
Drug: Control injection
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control injection (vehicle-containing local anaesthetic)
Trial: 8539544
Drug: Sulfamethoxazole-trimethoprim (SMX-TMP)
RxNorm normalized name: sulfamethoxazole / trimethoprim
DrugBank: Sulfamethoxazole (DB01015)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfamethoxazole-trimethoprim (SMX-TMP) 400/80 mg b.i.d.
Trial: 8539544
Drug: Aerosolized pentamidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized pentamidine (AP) 60 mg every 2nd week
Trial: 31900813
Drug: Medication providing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication providing a 'cure' with flu-like symptoms
Trial: 31900813
Drug: Medication providing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication providing a 'remission' labeled as 'cure' with flu-like symptoms
Trial: 31900813
Drug: Medication providing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication providing a 'remission' without labeling as 'cure'
Trial: 31687955
Drug: Nitroglycerin (8-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (8-10 μg/kg*min)
Trial: 27559692
Drug: E-cigarette administration
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: E-cigarette administration
Trial: 27559692
Drug: Tobacco cigarette
RxNorm normalized name: Tobacco leaf
DrugBank: Tobacco leaf (DB10710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobacco cigarette administration
Trial: 11943448
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy alone
Trial: 17533020
Drug: Atorvastatin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin, 40 mg/d for 6 weeks
Trial: 17533020
Drug: Gemfibrozil, 600
RxNorm normalized name: Gemfibrozil, 600 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil, 600 mg twice daily for 6 weeks
Trial: 15576517
Drug: Oxycodone 10
RxNorm normalized name: oxycodone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 10 mg with acetaminophen 650 mg
Trial: 8306408
Drug: L-AdVP (doxorubicin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-AdVP (doxorubicin, vincristine, prednisolone, and L-asparaginase)
Trial: 8306408
Drug: L-AdVP
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-AdVP
Trial: 2647291
Drug: Human lymphoblastoid
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human lymphoblastoid interferon (IFN) administered i.m. at doses of 1 x 10(6) units/m2, 3 x 10(6) units/m2, and 10 x 10(6) units/m2
Trial: 2647291
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of WBH and human lymphoblastoid IFN
Trial: 2647291
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy with IFN
Trial: 52367
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy (quintuple drug regimen: mechloretamine, adriamycin, bleomycin, vincristine, and prednisone)
Trial: 52367
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy (quintuple drug regimen)
Trial: 52367
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy followed by involved field irradiation
Trial: 29886347
Drug: Nurse-led group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led group treatment based on CBT-I (n=90)
Trial: 29886347
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (n=75)
Trial: 28756415
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (CBT, RTW-I, COMBO)
Trial: 14558436
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg manidipine dihydrochloride
Trial: 14558436
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg delapril hydrochloride
Trial: 14558436
Drug: Simultaneous administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simultaneous administration of 10 mg manidipine and 30 mg delapril
Trial: 3880714
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg penicillamine
Trial: 3880714
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg penicillamine
Trial: 27344823
Drug: He's fire
FDA approved: no
EMA approved: no
PMDA approved: no
Description: He's fire needle therapy applied for 8 weeks
Trial: 22420830
Drug: 0.06 mg.kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.06 mg.kg(‐1) rocuronium priming followed by 0.54 mg.kg(‐1) rocuronium
Trial: 22420830
Drug: 50 mg.kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg.kg(‐1) magnesium sulphate
Trial: 22420830
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of magnesium sulphate and rocuronium priming
Trial: 22420830
Drug: 0.6 mg.kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg.kg(‐1) rocuronium
Trial: 17660483
Drug: Oral roflumilast
RxNorm normalized name: Roflumilast
DrugBank: Roflumilast (DB01656)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral roflumilast 500 mug, once daily
Trial: 17660483
Drug: Concomitant administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concomitant administration of roflumilast and budesonide
Trial: 9589648
Drug: Miglitol 25
RxNorm normalized name: miglitol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miglitol 25 mg TID
Trial: 9589648
Drug: Miglitol 50
RxNorm normalized name: miglitol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miglitol 50 mg TID
Trial: 9589648
Drug: Glyburide (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide (titrated dose)
Trial: 7978718
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol 1 mg/d
Trial: 7978718
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol 2 mg/d
Trial: 8879340
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor (cilazapril)
Trial: 31393029
Drug: MI‐SI plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MI‐SI plus treatment as usual (TAU)
Trial: 31393029
Drug: MI‐SI‐R plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MI‐SI‐R plus treatment as usual (TAU)
Trial: 25110374
Drug: Three rounds
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three rounds of azithromycin mass drug administration (MDA)
Trial: 25110374
Drug: One round
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One round of azithromycin mass drug administration (MDA)
Trial: 22468770
Drug: Values of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Values of Life‐Sustaining Treatment Outcomes
Trial: 22468770
Drug: Dyad congruence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dyad congruence in values for life‐sustaining treatment
Trial: 17547539
Drug: DHA group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA group (BSF plus fish oil DHA 200 mg)
Trial: 7673021
Drug: Radiotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy with bromodeoxyuridine (BrdUrd) 0.8 g/m2 per day for 4 days of each of 3 weeks
Trial: 2041549
Drug: GM-1 ganglioside
RxNorm normalized name: IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 LIGHT CHAIN, DIMER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-1 ganglioside (100 mg intravenously per day for 18 to 32 doses)
Trial: 2041549
Drug: Placebo (intravenously
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenously per day for 18 to 32 doses)
Trial: 31784343
Drug: PrEP (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PrEP (300 mg tenofovir disoproxil fumarate and 200 mg emtricitabine per pill)
Trial: 30931709
Drug: 25% silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% silver nitrate (AgNO3) solution followed by a 5% sodium fluoride (NaF) varnish, semiannually (every 6 months)
Trial: 30931709
Drug: 38% silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 38% silver diamine fluoride (SDF) solution followed by a placebo varnish, semiannually (every 6 months)
Trial: 25976063
Drug: Carbetocin (100-µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbetocin (100-µg i.v. bolus)
Trial: 25976063
Drug: Intra-umbilical oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-umbilical oxytocin (50 IU in 30 mL saline)
Trial: 15942511
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (2 mg)
Trial: 15942511
Drug: Oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexamethasone (0.15 mg/kg)
Trial: 9787368
Drug: Dorzolamide-timolol combination
RxNorm normalized name: dorzolamide / timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide-timolol combination (2.0% dorzolamide and 0.5% timolol) administered twice daily
Trial: 9787368
Drug: 2.0% dorzolamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0% dorzolamide administered three times daily
Trial: 9787368
Drug: 0.5% timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% timolol administered twice daily
Trial: 27600055
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) 843 mg of (−)-epigallocatechin-3-gallate (EGCG)
Trial: 25869561
Drug: Fasudil (Rho
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasudil (Rho kinase inhibitor)
Trial: 15266215
Drug: Valdecoxib (10-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib (10-80 mg daily)
Trial: 15266215
Drug: Nonselective NSAIDs
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonselective NSAIDs (diclofenac 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid)
Trial: 15266215
Drug: Users of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Users of aspirin
Trial: 15266215
Drug: Valdecoxib (therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib (therapeutic doses 10 or 20 mg daily and supratherapeutic doses 40 or 80 mg daily)
Trial: 8833557
Drug: Pharmacist intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist intervention including diabetes education, medication counseling, dietary regulation, exercise, home blood glucose monitoring, and hypoglycemic regimen adjustment.
Trial: 3886357
Drug: Felodipine 5mg
RxNorm normalized name: FELODIPINE 5MG TAB,SA
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine 5mg three times daily
Trial: 3886357
Drug: Nifedipine 10mg
RxNorm normalized name: NIFEDIPINE 10MG CAP
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine 10mg three times daily
Trial: 31702056
Drug: Dexamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (8 mg in 2 mL)
Trial: 31702056
Drug: Tramadol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (100 mg in 2 mL)
Trial: 27884765
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg, Naproxen 200 mg, Oseltamivir 75 mg twice daily for 2 days, followed by Oseltamivir 75 mg twice daily for 3 days
Trial: 27884765
Drug: Oseltamivir 75
RxNorm normalized name: oseltamivir 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir 75 mg twice daily for 5 days (control)
Trial: 21367948
Drug: Carbohydrate-restricted diet
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-restricted diet (<20 g/d)
Trial: 19761358
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro protamine suspension (ILPS) 0.8 U/kg
Trial: 19761358
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (G) 0.8 U/kg
Trial: 19761358
Drug: Insulin detemir
RxNorm normalized name: Insulin Detemir
DrugBank: Insulin detemir (DB01307)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin detemir (D) 0.8 U/kg
Trial: 17045796
Drug: Continuous tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous tamoxifen (40 mg daily)
Trial: 17045796
Drug: Intermittent/alternated tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent/alternated tamoxifen and medroxyprogesterone acetate (MPA, 300 mg daily)
Trial: 9324165
Drug: NG‐monomethyl‐L‐arginine (L‐NMMA;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NG‐monomethyl‐L‐arginine (L‐NMMA; 4.0 micromol/kg x h)
Trial: 9324165
Drug: L‐arginine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐arginine (1 mmol/kg x h)
Trial: 8453706
Drug: Ifosfamide (3,750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ifosfamide (3,750 mg/m2 on days 1 and 2 every 3 weeks) + Doxorubicin (30 mg/m2 for 2 days)
Trial: 8453706
Drug: Doxorubicin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (80 mg/m2 every 3 weeks)
Trial: 8453706
Drug: Doxorubicin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (40 mg/m2) + Mitomycin (8 mg/m2) + Cisplatin (60 mg/m2, all given intravenously on day 1)
Trial: 31899723
Drug: Suprainguinal FICB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suprainguinal FICB with 30 mL of 0.375% ropivacaine
Trial: 31899723
Drug: Infrainguinal FICB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infrainguinal FICB with 30 mL of 0.375% ropivacaine
Trial: 25529756
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg day-1 ranitidine
Trial: 25529756
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg day-1 ranitidine
Trial: 8544269
Drug: GG167 (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GG167 (3.6 to 16 mg, administered intranasally two or six times daily)
Trial: 8544269
Drug: GG167 (early
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GG167 (early treatment)
Trial: 8544269
Drug: GG167 (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GG167 (twice daily dosing)
Trial: 1704089
Drug: Subcutaneous hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous hydromorphone infusion
Trial: 1704089
Drug: Intravenous hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydromorphone infusion
Trial: 788739
Drug: Phenylbutazone 300
RxNorm normalized name: phenylbutazone 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylbutazone 300 mg/day
Trial: 6884415
Drug: Phenylbutazone (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylbutazone (various doses: 90 mg, 150 mg, 180 mg, 240 mg, 270 mg, 300 mg, 360 mg, 450 mg/day)
Trial: 25448497
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of atorvastatin calcium and methylprednisolone
Trial: 21733697
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of fibrin spray administered topically during surgery
Trial: 21733697
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving neither treatment
Trial: 19268281
Drug: Acceptance-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance-based treatment for tinnitus distress
Trial: 9513583
Drug: Pranlukast (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranlukast (225 mg twice daily for 8 weeks)
Trial: 7844297
Drug: 10 percent
RxNorm normalized name: BENZOYL PEROXIDE 10 g in 100 mL TOPICAL LOTION [SMART RELEASE BPO 10 PERCENT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 percent carbamide peroxide bleaching gel (short application time)
Trial: 7844297
Drug: 10 percent
RxNorm normalized name: BENZOYL PEROXIDE 10 g in 100 mL TOPICAL LOTION [SMART RELEASE BPO 10 PERCENT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 percent carbamide peroxide bleaching gel (extended application time)
Trial: 3132124
Drug: Heparin (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (in patients with bleeding tendencies)
Trial: 31379269
Drug: Synbiotic supplementation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic supplementation (15 g of prebiotics, 5 g of probiotics containing Lactobacillus acidophilus T16, Bifidobacterium bifidum BIA-6, Bifidobacterium lactis BIA-7, and Bifidobacterium longum BIA-8 (2.7×107 CFU/g each))
Trial: 31379269
Drug: Probiotic supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic supplementation (5 g probiotics with 15 g of maltodextrin as placebo)
Trial: 30617950
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 g of maltodextrin)
Trial: 29231426
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (group B)
Trial: 25467221
Drug: Nabilone (NAB)
RxNorm normalized name: Nabilone
DrugBank: Nabilone (DB00486)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nabilone (NAB) 0.5 mg to 3.0 mg
Trial: 23246307
Drug: DTaP-IPV-Hep B-PRP-T
RxNorm normalized name: Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim)
Trial: 21586234
Drug: Telbivudine 600
RxNorm normalized name: telbivudine 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telbivudine 600 mg daily for 52 weeks
Trial: 21586234
Drug: Entecavir 0.5
RxNorm normalized name: entecavir 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entecavir 0.5 mg daily for 52 weeks
Trial: 16549733
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics (3 doses of 1200 mg intravenous amoxicillin-clavulanate at induction and 6 and 12 hours postoperatively)
Trial: 16549733
Drug: Postoperative antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative antibiotics (7-day course of 375 mg amoxicillin-clavulanate 3 times a day)